title: Visual acuity outcome in RADIANCE study patients with dome-shaped macular features.
authors.affiliation: Department of Ophthalmology, Inselspital, University Hospital, University of Bern, Switzerland.
authors.forename: Lala
authors.initials: L
authors.lastname: Ceklic
authors.affiliation: Department of Ophthalmology, Inselspital, University Hospital, University of Bern, Switzerland.
authors.forename: Ute
authors.initials: U
authors.lastname: Wolf-Schnurrbusch
authors.affiliation: Novartis Pharma AG, Basel, Switzerland.
authors.forename: Margarita
authors.initials: M
authors.lastname: Gekkieva
authors.affiliation: Department of Ophthalmology, Inselspital, University Hospital, University of Bern, Switzerland. Electronic address: sebastian.wolf@insel.ch.
authors.forename: Sebastian
authors.initials: S
authors.lastname: Wolf
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use; D000068258:Bevacizumab; D020256:Choroidal Neovascularization / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D005260:Female; D006801:Humans; D008266:Macula Lutea / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D047728:Myopia, Degenerative / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D000069579:Ranibizumab; D012189:Retrospective Studies; D041623:Tomography, Optical Coherence; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors; D014792:Visual Acuity / Q000502:physiology*; D055815:Young Adult
chemical_list: D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A; D000068258:Bevacizumab; D000069579:Ranibizumab